RB1 and retinoblastoma: However, a lower dose of etoposide (5 μM) did not show enhanced cell killing effects in combination with 1 μM olaparib in the primary retinoblastoma cells, while the enhanced killing effects were still observed in RB knocked-down U2OS cells.